Cargando…

Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations

Hydroxychloroquine (HCQ) and favipiravir (FPV) are known to be effective antivirals, and there are reports about their use to fight the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite that these are not conclusive. The use of combined drugs is common in drug discovery, and thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parlak, Cemal, Alver, Özgür, Ouma, Cecil Naphtaly Moro, Rhyman, Lydia, Ramasami, Ponnadurai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562770/ https://www.ncbi.nlm.nih.gov/pubmed/34744292 http://dx.doi.org/10.1007/s11696-021-01946-8

Ejemplares similares

Computational study of the interaction of the psychoactive amphetamine with 1,2-indanedione and 1,8-diazafluoren-9-one as fingerprinting reagents
por: Bhikharee, Divya, et al.
Publicado: (2023)

Theoretical study of the molecular aspect of the suspected novichok agent A234 of the Skripal poisoning
por: Bhakhoa, Hanusha, et al.
Publicado: (2019)

Theoretical study of a derivative of chlorophosphine with aliphatic and aromatic Grignard reagents: S(N)2@P or the novel S(N)2@Cl followed by S(N)2@C?
por: Savoo, Nandini, et al.
Publicado: (2022)

Theoretical studies on cycloaddition reactions
por: Rhyman, Lydia, et al.
Publicado: (2014)

Theoretical Study of the Microhydration the Chemical Warfare Agent Sulfur Mustard
por: Emambocus, Shëyhaane A., et al.
Publicado: (2020)

Synthesis and Photophysical Properties of Polycarbo-Substituted Quinazolines Derived from the 2-Aryl-4-chloro-6-iodoquinazolines
por: Mphahlele, Malose Jack, et al.
Publicado: (2015)

Spectroscopic, Electrochemical and DFT Studies of Phosphorescent Homoleptic Cyclometalated Iridium(III) Complexes Based on Substituted 4-Fluorophenylvinyl- and 4-Methoxyphenylvinylquinolines
por: Adeloye, Adewale O., et al.
Publicado: (2017)

Spectroscopic, DFT, and XRD Studies of Hydrogen Bonds in N-Unsubstituted 2-Aminobenzamides
por: Mphahlele, Malose Jack, et al.
Publicado: (2017)

“Smart” Triiodide Compounds: Does Halogen Bonding Influence Antimicrobial Activities?
por: Edis, Zehra, et al.
Publicado: (2019)

DFT exploration of [3 + 2] cycloaddition reaction of 1H-phosphorinium-3-olate and 1-methylphosphorinium-3-olate with methyl methacrylate
por: Hallooman, Dhanashree, et al.
Publicado: (2018)

Synthesis, Structure, Hirshfeld Surface Analysis, Non-Covalent Interaction, and In Silico Studies of 4-Hydroxy-1-[(4-Nitrophenyl)Sulfonyl]Pyrrolidine-2-Carboxyllic Acid
por: Ugwu, David Izuchukwu, et al.
Publicado: (2023)

Insight into the adsorption of a liquid organic hydrogen carrier, perhydro-i-dibenzyltoluene (i = m, o, p), on Pt, Pd and PtPd planar surfaces
por: Moro Ouma, Cecil Naphtaly, et al.
Publicado: (2018)

Computational Approaches to Alkaline Anion-Exchange Membranes for Fuel Cell Applications
por: Ouma, Cecil Naphtaly Moro, et al.
Publicado: (2022)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)

Photoelectrocatalytic application of palladium decorated zinc oxide-expanded graphite electrode for the removal of 4-nitrophenol: experimental and computational studies
por: Umukoro, Eseoghene H., et al.
Publicado: (2018)

A theoretical study of the hydrolysis mechanism of A-234; the suspected novichok agent in the Skripal attack
por: Imrit, Yadhav A., et al.
Publicado: (2020)

Unveiling the non-polar [3+2] cycloaddition reactions of cyclic nitrones with strained alkylidene cyclopropanes within a molecular electron density theory study
por: Domingo, Luis R., et al.
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Various toxicities: 7 case reports
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Detailed Analyses of Molecular Interactions between Favipiravir and RNA Viruses In Silico
por: Shirai, Tatsuya, et al.
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study
por: Alotaibi, Musim, et al.
Publicado: (2021)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers
por: Turan, Derya Bayırlı, et al.
Publicado: (2022)

Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
por: Surabotsophon, Manoon, et al.
Publicado: (2020)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
por: Bosaeed, Mohammad, et al.
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir
por: Alosaimi, Bandar, et al.
Publicado: (2022)

EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA
por: Delen, Leman Acun, et al.
Publicado: (2022)

Favipiravir/methotrexate interaction: Hepatotoxicity due to drug interaction: case report
Publicado: (2021)

RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones
por: Agbo, Emmanuel Ndubuisi, et al.
Publicado: (2015)

Structure and Computational Studies of New Sulfonamide Compound: {(4-nitrophenyl)sulfonyl}tryptophan
por: Eze, Florence Uchenna, et al.
Publicado: (2022)

Theoretical investigation of favipiravir antiviral drug based on fullerene and boron nitride nanocages
por: Soliman, Kamal A., et al.
Publicado: (2021)

Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
por: Anil Kumar, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_diu65h4c9pu61hetpajm66mdpe